Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Business intelligence is crucial in the decision-making process of
pharmaceutical and biopharmaceutical companies as they increase their levels
of external development and manufacturing. It also is vitally important for
contract service providers in evaluating their competitive advantage. Nice
Insight’s data facilitates that knowledge for the players in pharmaceutical
outsourcing. At Pharmaceutical Technology, we also use their research to
spot and track the trends we write about."
Michelle Hoffman Editorial Director,Pharmaceutical Drug Development and Manufacturing Group, Advanstar Pharmaceutical  
Pharma Chem Outsourcing 2013
September 16-18 Long Branch, NJ |
Ash Stevens, Inc. Asymchem Laboratories Inc. Fujifilm Diosynth Biotechnologies Cambrex Corporation Dishman Pharmaceuticals Aptalis Pharmaceutical Technologies Helsinn Laureate Biopharmaceutical Services, Inc. Northern Lipids, Inc. Pharmalytica Services, LLC Agere Pharmaceuticals, Inc.
Agere Pharmaceuticals, Inc. provides solutions to the development of poorly soluble compounds. Customers access Agere technology through fee-for-service, co-development and cost-sharing, strategic alliance or partnering arrangements. Agere integrates scientific knowledge and formulation expertise with analytical methods and predictive computational tools to de-risk compound progression. The company’s experience in formulation, compound advancement, and drug delivery is utilized to select and optimize discovery leads; identify and execute optimum formulation strategies; increase oral bioavailability; develop stable parenteral formulations; predict long-term formulation stability; predict in vivo performance; and manufacture materials for in vivo studies. http://www.agerepharma.com
Regions
Americas Stock Symbol Private Filter of Agere Pharmaceuticals, Inc.'s services per Nice Insight Categories
Contact Agere Pharmaceuticals, Inc. 
|
|
|
